| Current Price | $13.63 | Mkt Cap | $1.0B |
|---|---|---|---|
| Open | $14.47 | P/E Ratio | 0.00 |
| Prev. Close | $14.68 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $13.61 - $14.66 | Volume | 583,946 |
| 52-Wk Range | $11.70 - $22.82 | Avg. Daily Vol. | 834,311 |
| Current Price | $13.63 | Mkt Cap | $1.0B |
|---|---|---|---|
| Open | $14.47 | P/E Ratio | 0.00 |
| Prev. Close | $14.68 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $13.61 - $14.66 | Volume | 583,946 |
| 52-Wk Range | $11.70 - $22.82 | Avg. Daily Vol. | 834,311 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about FATE.
Recs
shanelofgren
(< 20)
Submitted: 9/25/2018 10:15:15 AM :
Start Price:
$9.49
NASDAQ:FATE Score:
+29.48
Bet on iPSC derived T cells for adoptive cell therapy.
Recs
NoPlaceLikeHome
(41.55)
Submitted: 3/9/2017 10:28:18 AM :
Start Price:
$4.09
NASDAQ:FATE Score:
+207.75
With a phase 3 trial that can support an FDA application for approval of Zilretta, a non-opioid therapy for knee pain in osteoarthritis patients, under their belt, they are on the road to final approval. Long story short, if it gets the FDA green light, 10% market penetration is over $1B in revenue. It is non-opiod which means prescribers and patients do not have to hassle with increased scrutiny writing and filling scripts and I believe that will make market penetration very easy. At under $200 million in market cap and a $1B+ opportunity, I can't pass up the risk/reward. Buy!!
Recs
oscillation
(68.45)
Submitted: 2/11/2016 1:26:54 PM :
Start Price:
$1.72
NASDAQ:FATE Score:
+631.44
nev
Find the members with the highest scoring picks in FATE.
stainsolution (< 20) Score: +716.30
The Score Leader is the player with the highest score across all their picks in FATE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| stainsolution | < 20 | 2/17/2016 |
|
5Y | $1.57 | +770.93% | +54.63% | +716.30 | 0 Comment | |
| oscillation | 68.45 | 2/11/2016 |
|
5Y | $1.72 | +694.75% | +63.31% | +631.44 | 1 Comment | |
|
biznessdoc | 62.33 | 8/15/2016 |
|
5Y | $2.57 | +430.35% | +36.24% | +394.11 | 0 Comment |
| portefeuille2 | 98.63 | 8/17/2016 |
|
5Y | $2.65 | +414.34% | +36.80% | +377.54 | 0 Comment | |
| shonny2 | < 20 | 2/6/2017 |
|
5Y | $2.87 | +374.91% | +30.30% | +344.61 | 0 Comment | |
| NoPlaceLikeHome | 41.55 | 3/9/2017 |
|
5Y | $4.09 | +233.66% | +25.91% | +207.75 | 3 Comments | |
| Under5 | < 20 | 11/16/2017 |
|
5Y | $4.40 | +209.77% | +15.26% | +194.51 | 0 Comment | |
|
|
TruffelPig | < 20 | 3/1/2017 |
|
5Y | $4.40 | +209.77% | +25.10% | +184.68 | 0 Comment |
| skellsmother | < 20 | 11/11/2013 |
|
1Y | $4.45 | +206.29% | +68.20% | +138.09 | 1 Comment | |
| cyberterrorist | < 20 | 11/12/2013 |
|
1Y | $4.51 | +202.22% | +68.54% | +133.67 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackWedbush | 88.34 | 10/28/2013 |
|
NS | $7.10 | +91.97% | +69.55% | +22.42 | 0 Comment |
